BRPI0620268B8 - composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo - Google Patents

composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo

Info

Publication number
BRPI0620268B8
BRPI0620268B8 BRPI0620268A BRPI0620268A BRPI0620268B8 BR PI0620268 B8 BRPI0620268 B8 BR PI0620268B8 BR PI0620268 A BRPI0620268 A BR PI0620268A BR PI0620268 A BRPI0620268 A BR PI0620268A BR PI0620268 B8 BRPI0620268 B8 BR PI0620268B8
Authority
BR
Brazil
Prior art keywords
biologically active
controlled release
active agent
protecting
manufacture
Prior art date
Application number
BRPI0620268A
Other languages
English (en)
Inventor
Maskiewicz Richard
Original Assignee
Oakwood Laboratories LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Oakwood Laboratories LLC filed Critical Oakwood Laboratories LLC
Publication of BRPI0620268A2 publication Critical patent/BRPI0620268A2/pt
Publication of BRPI0620268B1 publication Critical patent/BRPI0620268B1/pt
Publication of BRPI0620268B8 publication Critical patent/BRPI0620268B8/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats

Abstract

sistema de fornecimento com liberação controlada sublimável e método de fabricar o mesmo. a invenção refere-se a composições apropriadas para o fornecimento e/ou estabilização de substâncias biologicamente ativas. as composições compreendem um material de matriz sublimável e o agente biologicamente ativo a ser fornecido. as composições podem ser utilizadas como sistemas de fornecimento de droga para tratar uma ampla variedade de doenças ou como sistemas para a proteção e estabilização de tais substâncias. são também revelados métodos para preparar composições da presente invenção.
BRPI0620268A 2005-12-22 2006-12-22 composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo BRPI0620268B8 (pt)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US75311405P 2005-12-22 2005-12-22
US60/753.114 2005-12-22
PCT/US2006/062529 WO2007076462A2 (en) 2005-12-22 2006-12-22 Sublimable sustained release delivery system and method of making same

Publications (3)

Publication Number Publication Date
BRPI0620268A2 BRPI0620268A2 (pt) 2011-11-08
BRPI0620268B1 BRPI0620268B1 (pt) 2019-11-05
BRPI0620268B8 true BRPI0620268B8 (pt) 2021-05-25

Family

ID=38218838

Family Applications (1)

Application Number Title Priority Date Filing Date
BRPI0620268A BRPI0620268B8 (pt) 2005-12-22 2006-12-22 composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo

Country Status (8)

Country Link
US (2) US9301919B2 (pt)
EP (1) EP1962586B1 (pt)
JP (1) JP5276448B2 (pt)
CN (1) CN101511170B (pt)
AU (1) AU2006330526B2 (pt)
BR (1) BRPI0620268B8 (pt)
ES (1) ES2643140T3 (pt)
WO (1) WO2007076462A2 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5276448B2 (ja) * 2005-12-22 2013-08-28 オークウッド ラボラトリーズ，エル．エル．シー． 昇華可能な持続放出デリバリーシステム及びその製造方法
CA2730760A1 (en) * 2008-07-16 2010-01-21 Surmodics Pharmaceuticals, Inc. Process for preparing microparticles containing bioactive peptides
CN103172525B (zh) * 2013-02-17 2014-12-31 华南农业大学 一种乙基香兰素抗原和抗体的制备方法及其应用
JP7030440B2 (ja) * 2017-07-27 2022-03-07 株式会社Ｓｃｒｅｅｎホールディングス 基板処理方法、基板処理液及び基板処理装置
CN109504046B (zh) * 2018-12-18 2020-12-04 广州泽田餐饮用品实业有限公司 一种可光氧降解的pet复合材料及其制备方法与应用

Family Cites Families (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3608549A (en) * 1970-01-15 1971-09-28 Merrill Edward Wilson Method of administering drugs and capsule therefor
US4045551A (en) * 1973-01-19 1977-08-30 Ogawa & Co., Ltd. Sublimable aromatic compositions
US4123525A (en) * 1973-06-15 1978-10-31 Ogawa & Co., Ltd. Sublimable insecticidal compositions containing triisopropyl- or tritertiary-butyl-s-trioxane carriers
US4210640A (en) * 1973-06-15 1980-07-01 Ogawa & Co., Ltd. Sublimable fungicidal compositions containing triisopropyl- or tritertiary-butyl-s-trioxane carriers
DE2422321C2 (de) * 1973-06-15 1983-11-24 Ogawa & Co., Ltd., Osaka Sublimierbare Mittel für die Landwirtschaft
JPS564269B2 (pt) * 1973-07-10 1981-01-29
JPS5429566B2 (pt) * 1974-09-13 1979-09-25
US4093709A (en) * 1975-01-28 1978-06-06 Alza Corporation Drug delivery devices manufactured from poly(orthoesters) and poly(orthocarbonates)
US4400532A (en) * 1976-06-23 1983-08-23 Massachusetts Institute Of Technology Cryogenically controlled direct fluorination process, apparatus and products resulting therefrom
US4105798A (en) * 1976-07-19 1978-08-08 Sun Ventures, Inc. Perfluoro polycyclic compounds for use as synthetic blood and perfusion media
US4233161A (en) * 1976-12-25 1980-11-11 Idemitsu Kosan Company Limited Sublimable composition
US4301043A (en) * 1976-12-25 1981-11-17 Idemitsu Kosan Company Limited Sublimable perfume compositions
JPS6026090B2 (ja) 1977-09-22 1985-06-21 株式会社資生堂 化粧料
US4389330A (en) * 1980-10-06 1983-06-21 Stolle Research And Development Corporation Microencapsulation process
EP0126791B1 (de) * 1983-05-27 1988-07-20 Consortium für elektrochemische Industrie GmbH Festkörper für das Abgeben von Duftstoffen und/oder Desinfektionsmitteln
US4855134A (en) * 1983-10-14 1989-08-08 Sumitomo Pharmaceuticals Company, Limited Sustained-release preparation
JPS6166777A (ja) 1984-09-10 1986-04-05 Nitto Electric Ind Co Ltd 活性物質徐放体
US5411951A (en) * 1984-10-04 1995-05-02 Monsanto Company Prolonged release of biologically active somatotropin
JPS61293911A (ja) * 1985-06-24 1986-12-24 Teisan Seiyaku Kk 徐放化製剤
IL78826A (en) * 1986-05-19 1991-05-12 Yissum Res Dev Co Precursor composition for the preparation of a biodegradable implant for the sustained release of an active material and such implants prepared therefrom
IT1198449B (it) * 1986-10-13 1988-12-21 F I D I Farmaceutici Italiani Esteri di alcoli polivalenti di acido ialuronico
US5278135A (en) * 1989-02-18 1994-01-11 E. I. Du Pont De Nemours And Company Ceramic/distillable binder compositions
JPH02280771A (ja) 1989-04-24 1990-11-16 Descente Ltd 経皮薬物徐放繊維及び経皮薬物徐放繊維で構成した被服素材
US5292530A (en) * 1991-06-02 1994-03-08 Helene Curtis, Inc. Stable anhydrous topically-active composition and suspending agent therefor
US5518731A (en) * 1990-09-27 1996-05-21 Allergan, Inc. Nonaqueous fluorinated drug delivery vehicle suspensions
DE69108739T2 (de) * 1990-12-07 1995-09-14 Upjohn Co Phosphonsäurederivate als entzündungshemmende mittel.
YU87892A (sh) * 1991-10-01 1995-12-04 Eli Lilly And Company Lilly Corporate Center Injektibilne formulacije produženog otpuštanja i postupci za njihovo dobijanje i primenu
DE69408527T2 (de) * 1993-03-09 1998-06-04 Epic Therapeutics Inc Makromolekulare mikropartikel und verfahren zu ihrer herstellung
CN1051672C (zh) 1993-03-27 2000-04-26 何萍 新型驱蚊防蚊组合物
AU7564494A (en) * 1993-08-13 1995-03-14 Smith & Nephew Richards Inc. Microporous polymeric foams and microtextured surfaces
US5456247A (en) * 1993-08-26 1995-10-10 Iowa State University Research Foundation, Inc. Method for delivering drugs soluble in a vaporization vehicle
JPH07112940A (ja) * 1993-08-26 1995-05-02 Takeda Chem Ind Ltd 徐放性非経口投与製剤およびその製造方法
CN1040941C (zh) 1993-11-05 1998-12-02 大日本除虫菊株式会社 衣料用杀虫、防虫组合物
US5686091A (en) * 1994-03-28 1997-11-11 The Johns Hopkins University School Of Medicine Biodegradable foams for cell transplantation
US5747058A (en) * 1995-06-07 1998-05-05 Southern Biosystems, Inc. High viscosity liquid controlled delivery system
US5736152A (en) * 1995-10-27 1998-04-07 Atrix Laboratories, Inc. Non-polymeric sustained release delivery system
US5792477A (en) * 1996-05-07 1998-08-11 Alkermes Controlled Therapeutics, Inc. Ii Preparation of extended shelf-life biodegradable, biocompatible microparticles containing a biologically active agent
US5932547A (en) * 1996-07-03 1999-08-03 Alza Corporation Non-aqueous polar aprotic peptide formulations
IN184589B (pt) * 1996-10-16 2000-09-09 Alza Corp
US6143276A (en) * 1997-03-21 2000-11-07 Imarx Pharmaceutical Corp. Methods for delivering bioactive agents to regions of elevated temperatures
IN186245B (pt) * 1997-09-19 2001-07-14 Ranbaxy Lab Ltd
US6245740B1 (en) * 1998-12-23 2001-06-12 Amgen Inc. Polyol:oil suspensions for the sustained release of proteins
US6395300B1 (en) * 1999-05-27 2002-05-28 Acusphere, Inc. Porous drug matrices and methods of manufacture thereof
EP1200140A1 (en) * 1999-08-03 2002-05-02 Smith & Nephew, Inc. Controlled release implantable devices
AP2002002410A0 (en) 1999-08-04 2002-03-31 Ranbaxy Laboratories Ltd Hydrodynamically Balancing Oral Drug Delivery System
AU6639400A (en) * 1999-08-18 2001-03-13 Microchips, Inc. Thermally-activated microchip chemical delivery devices
US20020001617A1 (en) * 2000-05-26 2002-01-03 Chang-Hyun Lee Rapidly disintegrating tablet and process for the manufacture thereof
US20060099245A1 (en) * 2000-08-01 2006-05-11 Manoj Kumar Hydrodynamically balancing oral drug delivery system with biphasic release
JP2003125706A (ja) * 2001-10-23 2003-05-07 Lion Corp 口中清涼製剤
EP2087882A1 (en) * 2002-03-26 2009-08-12 Teva Pharmaceutical Industries Ltd. Drug microparticles
US7138394B2 (en) * 2002-09-27 2006-11-21 Alpharx Inc. Vehicle for topical delivery of anti-inflammatory compounds
JP2004202370A (ja) * 2002-12-25 2004-07-22 Nippon Nohyaku Co Ltd 水処理剤及びその使用方法
CN1731984A (zh) * 2003-01-15 2006-02-08 陶氏环球技术公司 通过在冷表面上冰冻得到的药物粒子
US7803395B2 (en) * 2003-05-15 2010-09-28 Biomerix Corporation Reticulated elastomeric matrices, their manufacture and use in implantable devices
US7223761B2 (en) * 2003-10-03 2007-05-29 Amgen Inc. Salts and polymorphs of a potent antidiabetic compound
EP1747017B1 (en) * 2004-05-10 2008-03-26 Robert F. Hofmann Use of targeted oxidative therapeutic formulation in treatment of age-related macular degeneration
KR101341359B1 (ko) * 2004-10-01 2013-12-13 램스코르 인코포레이티드 편리하게 이식가능한 서방형 약물 조성물
JP5276448B2 (ja) 2005-12-22 2013-08-28 オークウッド ラボラトリーズ，エル．エル．シー． 昇華可能な持続放出デリバリーシステム及びその製造方法
US20070219127A1 (en) 2006-03-20 2007-09-20 Walt John G Cyclosporin a compositions

Also Published As

Publication number Publication date
CN101511170B (zh) 2014-03-26
WO2007076462A3 (en) 2007-11-08
US9301919B2 (en) 2016-04-05
WO2007076462A2 (en) 2007-07-05
JP5276448B2 (ja) 2013-08-28
BRPI0620268A2 (pt) 2011-11-08
US8987340B2 (en) 2015-03-24
US20090220602A1 (en) 2009-09-03
AU2006330526A1 (en) 2007-07-05
EP1962586A4 (en) 2012-10-03
AU2006330526B2 (en) 2012-09-27
EP1962586B1 (en) 2017-07-12
US20070148098A1 (en) 2007-06-28
ES2643140T3 (es) 2017-11-21
CN101511170A (zh) 2009-08-19
BRPI0620268B1 (pt) 2019-11-05
EP1962586A2 (en) 2008-09-03
JP2009533316A (ja) 2009-09-17

Similar Documents

Publication Publication Date Title
BR112018002227A2 (pt) composições com potencializadores de permeação para administração de fármaco
GT199900203A (es) Composiciones de celecoxib.
BRPI1007379B8 (pt) composições farmacêuticas para o tratamento ou prevenção de infecções orais por e. coli
BRPI0518255A2 (pt) mÉtodos de tratamento ou prevenÇço de uma lesço do sistema nervoso central, para reduzir ou evitar um efeito adverso, e composiÇço farmacÊutica
DE602005013244D1 (de) Pharmazeutische zusammensetzungen für die kontroll
BR0209040A (pt) Processo para preparar uma fase de fosfato de cálcio, fase de fosfato de cálcio, substrato de fase de fosfato de cálcio, e, microesfera
BRPI0517640A (pt) composições farmacêuticas tópicas contendo um composto antiacne e um composto antibiótico
BRPI0620268B8 (pt) composição eficaz como sistema de fornecimento para liberação controlada, seu uso, seu método de fabricação, e método para proteger um agente biologicamente ativo
DOP2009000135A (es) Derivados de 2,3-dihidroimidazo [1,2-c] quinazolina sustituídos de utilidad en el tratamiento de trastornos hiperproliferativos y enfermedades asociadas con la angiogénesis
BRPI0509172A (pt) pelo menos uma entidade quìmica, composição farmacêutica, métodos para tratar um paciente, para inibir pelo menos uma enzima que utiliza atp, e para tratar pelo menos uma doença, uso de pelo menos uma entidade quìmica, e, método para a fabricação de um medicamento
BRPI0416032A (pt) excipientes em veìculos de distribuição de fármacos
TR200500745T2 (tr) Damar gelişimi inhibitörleri olarak kuinazolin türevleri.
UY31673A1 (es) "derivados heterocíclicos de urea y métodos de uso de los mismos-211"
BRPI0416590A (pt) excipientes em veìculos de distribuição de fármacos
BRPI0518999A2 (pt) composiÇÕes e mÉtodos para tratar condiÇÕes da unidade da unha
WO2007092284A3 (en) Low dose no donor-containing transdermal patch
BR0007487A (pt) Difenil-uréias substituìdas com w-carbóxi-arilas como inibidores de raf cinase
BRPI0607927A2 (pt) derivados de pirazol-pirimidina
BRPI0306993B8 (pt) polímero de polialquilenoglicol ativado; composição; e uso de um composto na produção de um medicamento para o tratamento de esclerose múltipla ou infecção viral suscetível
ATE459345T1 (de) Wirkstoffpartikelhaltiges transdermales therapeutisches system mit erhöhtem wirkstofffluss
BRPI0318278B8 (pt) Compostos de éter aminocicloexílico, composição compreendendo ditos compostos, usos dos mesmos e método para modular a atividade do canal iônico em um ambiente in vitro
BRPI0612125A2 (pt) compostos da fórmula (i), processo para a fabricação destes, composto da fórmula iiia, composições farmacêuticas, método para o tratamento e/ou profilaxia de doenças associadas à modulação dos receptores cb1 e uso de compostos
TW200731975A (en) Novel combinations of medicaments for the treatment of respiratory diseases
CY1107906T1 (el) Φαρμακευτικη συνθεση που περιλαμβανει παραγωγα οιστετρολης για χρηση στην θεραπεια κατα του καρκινου
Shen et al. Tetracycline release from tripolyphosphate–chitosan cross‐linked sponge: a preliminary in vitro study

Legal Events

Date Code Title Description
B07D Technical examination (opinion) related to article 229 of industrial property law [chapter 7.4 patent gazette]
B06F Objections, documents and/or translations needed after an examination request according [chapter 6.6 patent gazette]
B07E Notification of approval relating to section 229 industrial property law [chapter 7.5 patent gazette]

Free format text: NOTIFICACAO DE ANUENCIA RELACIONADA COM O ART 229 DA LPI

B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B06A Patent application procedure suspended [chapter 6.1 patent gazette]
B09A Decision: intention to grant [chapter 9.1 patent gazette]
B16A Patent or certificate of addition of invention granted [chapter 16.1 patent gazette]

Free format text: PRAZO DE VALIDADE: 10 (DEZ) ANOS CONTADOS A PARTIR DE 05/11/2019, OBSERVADAS AS CONDICOES LEGAIS.

B16C Correction of notification of the grant [chapter 16.3 patent gazette]

Free format text: PRAZO DE VALIDADE: 20 (VINTE) ANOS CONTADOS A PARTIR DE 22/12/2006 OBSERVADAS AS CONDICOES LEGAIS. PATENTE CONCEDIDA CONFORME ADI 5.529/DF

B21F Lapse acc. art. 78, item iv - on non-payment of the annual fees in time

Free format text: REFERENTE A 17A ANUIDADE.

B24J Lapse because of non-payment of annual fees (definitively: art 78 iv lpi, resolution 113/2013 art. 12)

Free format text: EM VIRTUDE DA EXTINCAO PUBLICADA NA RPI 2754 DE 17-10-2023 E CONSIDERANDO AUSENCIA DE MANIFESTACAO DENTRO DOS PRAZOS LEGAIS, INFORMO QUE CABE SER MANTIDA A EXTINCAO DA PATENTE E SEUS CERTIFICADOS, CONFORME O DISPOSTO NO ARTIGO 12, DA RESOLUCAO 113/2013.